Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Supriya Lifescience Limited ( (IN:SUPRIYA) ) has issued an announcement.
Supriya Lifescience Limited has announced an upcoming earnings call scheduled for November 13, 2025, to discuss its operational and financial performance for the quarter and half-year ending September 30, 2025. This call is crucial for stakeholders as it provides insights into the company’s financial health and strategic direction, potentially impacting investor decisions and market positioning.
More about Supriya Lifescience Limited
Supriya Lifescience Limited operates in the pharmaceutical industry, focusing on the production and export of active pharmaceutical ingredients (APIs). The company is recognized as a government-approved export house, indicating its significant role in the global pharmaceutical supply chain.
Average Trading Volume: 16,284
Technical Sentiment Signal: Buy
Current Market Cap: 63.48B INR
Find detailed analytics on SUPRIYA stock on TipRanks’ Stock Analysis page.